RECURSION PHARMACEUTICALS INCRECURSION PHARMACEUTICALS INCRECURSION PHARMACEUTICALS INC

RECURSION PHARMACEUTICALS INC

No trades
See on Supercharts

Price target

185.800.000.00%
The 6 analysts offering 1 year price forecasts for RXRX have a max estimate of — and a min estimate of —.

Analyst rating

Based on 7 analysts giving stock ratings to RXRX in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


RXRX EPS for the last quarter is −6.70 MXN despite the estimation of −6.56 MXN. In the next quarter EPS is expected to reach −8.58 MXN. Track more of RECURSION PHARMACEUTICALS INC financials and stay on top of what is up with the company.
In the next quarter RECURSION PHARMACEUTICALS INC revenue is expected to reach ‪319.29 M‬ MXN. Check out RECURSION PHARMACEUTICALS INC revenue and earnings and make informed decisions.
According to analysts, RXRX price target is 185.80 MXN with a max estimate of 227.09 MXN and a min estimate of 123.87 MXN. Check if this forecast comes true in a year, meanwhile watch RECURSION PHARMACEUTICALS INC stock price chart and keep track of the current situation with RXRX news and stock market news.
We've gathered opinions of 7 analysts rating RXRX stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.